Ultra-large volume wearable injectors are a new innovation within the injectable drug delivery market. These injectors are used to deliver large (>1-2 mL) volumes of drugs to drug developers, clinicians, and patients.
LPI (LP Information)' newest research report, the “Ultra-large Volume Wearable Injectors Industry Forecast” looks at past sales and reviews total world Ultra-large Volume Wearable Injectors sales in 2022, providing a comprehensive analysis by region and market sector of projected Ultra-large Volume Wearable Injectors sales for 2023 through 2029. With Ultra-large Volume Wearable Injectors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ultra-large Volume Wearable Injectors industry.
This Insight Report provides a comprehensive analysis of the global Ultra-large Volume Wearable Injectors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ultra-large Volume Wearable Injectors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Ultra-large Volume Wearable Injectors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ultra-large Volume Wearable Injectors and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ultra-large Volume Wearable Injectors.
The global Ultra-large Volume Wearable Injectors market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Ultra-large Volume Wearable Injectors is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Ultra-large Volume Wearable Injectors is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Ultra-large Volume Wearable Injectors is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Ultra-large Volume Wearable Injectors players cover Ypsomed, Amgen, West Pharmaceuticals, Unilife Corporation, CeQur, Sensile Medical, BD Medical, Enable Injections and Sorrel Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Ultra-large Volume Wearable Injectors market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
On-Body Injectors
Off-Body Injectors
Segmentation by application
Hospitals
Clinics
Home Care Settings
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Ypsomed
Amgen
West Pharmaceuticals
Unilife Corporation
CeQur
Sensile Medical
BD Medical
Enable Injections
Sorrel Medical
E3D Elcam Drug Delivery Devices
Key Questions Addressed in this Report
What is the 10-year outlook for the global Ultra-large Volume Wearable Injectors market?
What factors are driving Ultra-large Volume Wearable Injectors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Ultra-large Volume Wearable Injectors market opportunities vary by end market size?
How does Ultra-large Volume Wearable Injectors break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Ultra-large Volume Wearable Injectors Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Ultra-large Volume Wearable Injectors by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Ultra-large Volume Wearable Injectors by Country/Region, 2018, 2022 & 2029 2.2 Ultra-large Volume Wearable Injectors Segment by Type 2.2.1 On-Body Injectors 2.2.2 Off-Body Injectors 2.3 Ultra-large Volume Wearable Injectors Sales by Type 2.3.1 Global Ultra-large Volume Wearable Injectors Sales Market Share by Type (2018-2023) 2.3.2 Global Ultra-large Volume Wearable Injectors Revenue and Market Share by Type (2018-2023) 2.3.3 Global Ultra-large Volume Wearable Injectors Sale Price by Type (2018-2023) 2.4 Ultra-large Volume Wearable Injectors Segment by Application 2.4.1 Hospitals 2.4.2 Clinics 2.4.3 Home Care Settings 2.4.4 Others 2.5 Ultra-large Volume Wearable Injectors Sales by Application 2.5.1 Global Ultra-large Volume Wearable Injectors Sale Market Share by Application (2018-2023) 2.5.2 Global Ultra-large Volume Wearable Injectors Revenue and Market Share by Application (2018-2023) 2.5.3 Global Ultra-large Volume Wearable Injectors Sale Price by Application (2018-2023) 3 Global Ultra-large Volume Wearable Injectors by Company 3.1 Global Ultra-large Volume Wearable Injectors Breakdown Data by Company 3.1.1 Global Ultra-large Volume Wearable Injectors Annual Sales by Company (2018-2023) 3.1.2 Global Ultra-large Volume Wearable Injectors Sales Market Share by Company (2018-2023) 3.2 Global Ultra-large Volume Wearable Injectors Annual Revenue by Company (2018-2023) 3.2.1 Global Ultra-large Volume Wearable Injectors Revenue by Company (2018-2023) 3.2.2 Global Ultra-large Volume Wearable Injectors Revenue Market Share by Company (2018-2023) 3.3 Global Ultra-large Volume Wearable Injectors Sale Price by Company 3.4 Key Manufacturers Ultra-large Volume Wearable Injectors Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Ultra-large Volume Wearable Injectors Product Location Distribution 3.4.2 Players Ultra-large Volume Wearable Injectors Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Ultra-large Volume Wearable Injectors by Geographic Region 4.1 World Historic Ultra-large Volume Wearable Injectors Market Size by Geographic Region (2018-2023) 4.1.1 Global Ultra-large Volume Wearable Injectors Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Ultra-large Volume Wearable Injectors Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Ultra-large Volume Wearable Injectors Market Size by Country/Region (2018-2023) 4.2.1 Global Ultra-large Volume Wearable Injectors Annual Sales by Country/Region (2018-2023) 4.2.2 Global Ultra-large Volume Wearable Injectors Annual Revenue by Country/Region (2018-2023) 4.3 Americas Ultra-large Volume Wearable Injectors Sales Growth 4.4 APAC Ultra-large Volume Wearable Injectors Sales Growth 4.5 Europe Ultra-large Volume Wearable Injectors Sales Growth 4.6 Middle East & Africa Ultra-large Volume Wearable Injectors Sales Growth 5 Americas 5.1 Americas Ultra-large Volume Wearable Injectors Sales by Country 5.1.1 Americas Ultra-large Volume Wearable Injectors Sales by Country (2018-2023) 5.1.2 Americas Ultra-large Volume Wearable Injectors Revenue by Country (2018-2023) 5.2 Americas Ultra-large Volume Wearable Injectors Sales by Type 5.3 Americas Ultra-large Volume Wearable Injectors Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Ultra-large Volume Wearable Injectors Sales by Region 6.1.1 APAC Ultra-large Volume Wearable Injectors Sales by Region (2018-2023) 6.1.2 APAC Ultra-large Volume Wearable Injectors Revenue by Region (2018-2023) 6.2 APAC Ultra-large Volume Wearable Injectors Sales by Type 6.3 APAC Ultra-large Volume Wearable Injectors Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Ultra-large Volume Wearable Injectors by Country 7.1.1 Europe Ultra-large Volume Wearable Injectors Sales by Country (2018-2023) 7.1.2 Europe Ultra-large Volume Wearable Injectors Revenue by Country (2018-2023) 7.2 Europe Ultra-large Volume Wearable Injectors Sales by Type 7.3 Europe Ultra-large Volume Wearable Injectors Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Ultra-large Volume Wearable Injectors by Country 8.1.1 Middle East & Africa Ultra-large Volume Wearable Injectors Sales by Country (2018-2023) 8.1.2 Middle East & Africa Ultra-large Volume Wearable Injectors Revenue by Country (2018-2023) 8.2 Middle East & Africa Ultra-large Volume Wearable Injectors Sales by Type 8.3 Middle East & Africa Ultra-large Volume Wearable Injectors Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Ultra-large Volume Wearable Injectors 10.3 Manufacturing Process Analysis of Ultra-large Volume Wearable Injectors 10.4 Industry Chain Structure of Ultra-large Volume Wearable Injectors 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Ultra-large Volume Wearable Injectors Distributors 11.3 Ultra-large Volume Wearable Injectors Customer 12 World Forecast Review for Ultra-large Volume Wearable Injectors by Geographic Region 12.1 Global Ultra-large Volume Wearable Injectors Market Size Forecast by Region 12.1.1 Global Ultra-large Volume Wearable Injectors Forecast by Region (2024-2029) 12.1.2 Global Ultra-large Volume Wearable Injectors Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Ultra-large Volume Wearable Injectors Forecast by Type 12.7 Global Ultra-large Volume Wearable Injectors Forecast by Application 13 Key Players Analysis 13.1 Ypsomed 13.1.1 Ypsomed Company Information 13.1.2 Ypsomed Ultra-large Volume Wearable Injectors Product Portfolios and Specifications 13.1.3 Ypsomed Ultra-large Volume Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Ypsomed Main Business Overview 13.1.5 Ypsomed Latest Developments 13.2 Amgen 13.2.1 Amgen Company Information 13.2.2 Amgen Ultra-large Volume Wearable Injectors Product Portfolios and Specifications 13.2.3 Amgen Ultra-large Volume Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Amgen Main Business Overview 13.2.5 Amgen Latest Developments 13.3 West Pharmaceuticals 13.3.1 West Pharmaceuticals Company Information 13.3.2 West Pharmaceuticals Ultra-large Volume Wearable Injectors Product Portfolios and Specifications 13.3.3 West Pharmaceuticals Ultra-large Volume Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 West Pharmaceuticals Main Business Overview 13.3.5 West Pharmaceuticals Latest Developments 13.4 Unilife Corporation 13.4.1 Unilife Corporation Company Information 13.4.2 Unilife Corporation Ultra-large Volume Wearable Injectors Product Portfolios and Specifications 13.4.3 Unilife Corporation Ultra-large Volume Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Unilife Corporation Main Business Overview 13.4.5 Unilife Corporation Latest Developments 13.5 CeQur 13.5.1 CeQur Company Information 13.5.2 CeQur Ultra-large Volume Wearable Injectors Product Portfolios and Specifications 13.5.3 CeQur Ultra-large Volume Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 CeQur Main Business Overview 13.5.5 CeQur Latest Developments 13.6 Sensile Medical 13.6.1 Sensile Medical Company Information 13.6.2 Sensile Medical Ultra-large Volume Wearable Injectors Product Portfolios and Specifications 13.6.3 Sensile Medical Ultra-large Volume Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Sensile Medical Main Business Overview 13.6.5 Sensile Medical Latest Developments 13.7 BD Medical 13.7.1 BD Medical Company Information 13.7.2 BD Medical Ultra-large Volume Wearable Injectors Product Portfolios and Specifications 13.7.3 BD Medical Ultra-large Volume Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 BD Medical Main Business Overview 13.7.5 BD Medical Latest Developments 13.8 Enable Injections 13.8.1 Enable Injections Company Information 13.8.2 Enable Injections Ultra-large Volume Wearable Injectors Product Portfolios and Specifications 13.8.3 Enable Injections Ultra-large Volume Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Enable Injections Main Business Overview 13.8.5 Enable Injections Latest Developments 13.9 Sorrel Medical 13.9.1 Sorrel Medical Company Information 13.9.2 Sorrel Medical Ultra-large Volume Wearable Injectors Product Portfolios and Specifications 13.9.3 Sorrel Medical Ultra-large Volume Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Sorrel Medical Main Business Overview 13.9.5 Sorrel Medical Latest Developments 13.10 E3D Elcam Drug Delivery Devices 13.10.1 E3D Elcam Drug Delivery Devices Company Information 13.10.2 E3D Elcam Drug Delivery Devices Ultra-large Volume Wearable Injectors Product Portfolios and Specifications 13.10.3 E3D Elcam Drug Delivery Devices Ultra-large Volume Wearable Injectors Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 E3D Elcam Drug Delivery Devices Main Business Overview 13.10.5 E3D Elcam Drug Delivery Devices Latest Developments 14 Research Findings and Conclusion